Introduced
Committee
Markup
Reported
Floor
Passed
Enacted
HR.4030 119th Congress

Treatment Continuity Act of 2025

Status
In Committee
Sponsor
Dunn, Neal P. (R-Florida)
Official Source
Investability
0/100
Stage
COMMITTEE
Related Bills
0
Full Text
2,736 chars
Alive
Yes
Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.
2025-06-17
Referred to the House Committee on Energy and Commerce.
2025-06-17
Introduced in House
2025-06-17
Introduced in House
119 HR 4030 IH: Treatment Continuity Act of 2025 U.S. House of Representatives 2025-06-17 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 4030 IN THE HOUSE OF REPRESENTATIVES June 17, 2025 Mr. Dunn of Florida (for himself, Mr. Soto , and Mr. Bean of Florida ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Public Health Service Act to authorize the Secretary of Health and Human Services to address priority substance use disorder and serious mental illness treatment needs through long-acting injectable medications, and for other purposes. 1. Short title This Act may be cited as the Treatment Continuity Act of 2025 . 2. Priority substance use disorder and serious mental illness treatment needs of regional and national significance (a) In general Section 509 of the Public Health Service Act ( 42 U.S.C. 290bb–2 ) is amended— (1) in the section heading, by inserting AND SERIOUS MENTAL ILLNESS after SUBSTANCE USE DISORDER ; (2) in subsection (a)— (A) in the matter preceding paragraph (1), by inserting and serious mental illness after substance use disorder ; and (B) by striking paragraphs (1) through (3) and inserting the following: (1) access to long-acting injectable medications that are approved by the Food and Drug Administration for the treatment of individuals with substance use disorders or serious mental illness; (2) lab testing and supportive counseling for substance use disorder and serious mental illness; and (3) training on the use of long-acting injectable medications for the purposes described in paragraph (1), in combination with associated clinical services such as counseling. ; (3) in subsection (b)— (A) in the subsection heading, by inserting and Serious Mental Illness after Substance Use Disorder ; and (B) in paragraphs (1) and (2), by inserting and serious mental illness after substance use disorder ; (4) by striking subsections (d) and (e) and inserting the following: (d) Annual report to Congress Not later than 1 year after the date of enactment of the Treatment Continuity Act of 2025, and annually thereafter during the term of the program under this section, the Secretary shall transmit to Congress a report on the outcomes of such program, including completed or substantial progress toward treatment requirements based on clinician assessment. ; and (5) by redesignating subsection (f) as subsection (e). (b) Applicability The amendments made by this section shall apply to grants made under section 509 of the Public Health Service Act after the date of the enactment of this Act.
🔒 GovGreed Pro · Trading Intelligence on HR.4030 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated recently.
Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records.
GovGreed is not affiliated with the U.S. Government. Not financial advice.